Press Releases about Kalvista Pharmaceuticals Inc
![](https://mms.businesswire.com/media/20240815998817/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240802335240/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240711453276/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240702602098/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240627071012/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240618507569/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240606656084/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240604383516/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240603431601/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240531104408/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240524679559/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240521674499/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240502658624/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240501899140/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240422400971/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240403658389/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240402778985/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240318610099/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240312355965/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240311841357/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240308093167/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240307682920/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240306952725/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240304835396/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240227931159/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240226691447/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240220763544/en/670569/5/Kalvista-Logo-Final-01.jpg)
KalVista Pharmaceuticals Awarded UK Innovation Passport for Sebetralstat
February 20, 2024
Via Business Wire
![](https://mms.businesswire.com/media/20240216185634/en/670569/5/Kalvista-Logo-Final-01.jpg)
![](https://mms.businesswire.com/media/20240215102633/en/670569/5/Kalvista-Logo-Final-01.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.